A Study to Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia on a Background of Lipid-lowering Therapy
Clinical trial NCT07421284 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07421284
- Sponsor
- CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-31
- Primary completion
- 2027-12-31
- Enrollment
- 900
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.